Want to see TSE:BCT full AI Analyst Report?
BriaCell Therapeutics (BCT) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Cyclophosphamide, Sv-Br-1-Gm, Retifanlimab, Interferon Infiltration Of The Inoculation Site, Treatment Of Physician's Choice | Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm, Breast Cancer Metastatic, End Stage Cancer | Phase III | Recruiting | Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. | Sep 25, 2023 | ― |
| Sv-Br-1-Gm, Low Dose Cyclophosphamide, Interferon Inoculation, Retifanlimab | Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm, Breast Cancer Metastatic | phase1AndPhase2 | Enrolling By Invitation | Combination Study of SV-BR-1-GM With Retifanlimab | Oct 23, 2017 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Cyclophosphamide, Sv-Br-1-Gm, Retifanlimab, Interferon Infiltration Of The Inoculation Site, Treatment Of Physician's Choice | Phase III | Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm, Breast Cancer Metastatic, End Stage Cancer | Recruiting | Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. | Sep 25, 2023 | ― |
| Sv-Br-1-Gm, Low Dose Cyclophosphamide, Interferon Inoculation, Retifanlimab | phase1AndPhase2 | Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm, Breast Cancer Metastatic | Enrolling By Invitation | Combination Study of SV-BR-1-GM With Retifanlimab | Oct 23, 2017 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does BriaCell Therapeutics (TSE:BCT) have in its pipeline
BriaCell Therapeutics TSE:BCT is currently developing the following drugs: Cyclophosphamide, Sv-Br-1-Gm, Retifanlimab, Interferon Infiltration Of The Inoculation Site, Treatment Of Physician's Choice, Sv-Br-1-Gm, Low Dose Cyclophosphamide, Interferon Inoculation, Retifanlimab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
